Relation of gemfibrozil treatment and high-density lipoprotein subpopulation profile with cardiovascular events in the Veterans Affairs High-Density Lipoprotein Intervention Trial

This publication has 29 references indexed in Scilit:

• Fibric acid derivatives in cardiovascular disease prevention: results from the large clinical trials
  Current Opinion in HIV and AIDS, 2006
• Cholesteryl ester transfer protein inhibition, high-density lipoprotein metabolism and heart disease risk reduction
  Current Opinion in Lipidology, 2006
• Change in α ₁ HDL Concentration Predicts Progression in Coronary Artery Stenosis
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2003
• Action of Atorvastatin in Combined Hyperlipidemia
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• Fenofibrate Reduces Plasma Cholesteryl Ester Transfer From HDL to VLDL and Normalizes the Atherogenic, Dense LDL Profile in Combined Hyperlipidemia
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1996
• The effects of fibrates on lipoprotein and hemostatic coronary risk factors
  Atherosclerosis, 1994
• Two-dimensional electrophoresis of plasma lipoproteins: Recognition of new apo A-I-containing subpopulations
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
• Rationale and design of the Department of Veterans Affairs high-density lipoprotein cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterol
  The American Journal of Cardiology, 1993
• Regulation of the concentration of pre.beta. high-density lipoprotein in normal plasma by cell membranes and lecithin-cholesterol acyltransferase activity
  Biochemistry, 1992
• Early incorporation of cell-derived cholesterol into pre-.beta.-migrating high-density lipoprotein
  Biochemistry, 1988